Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 980
5
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we make anesthesia for dogs safer with the help of nutrition?

Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

Backer Badge Funded